Life-threatening breathing difficulties can occur in patients who use gabapentin or pregabalin with opioids or other drugs that depress the central nervous system, as well as those with underlying respiratory impairment and the elderly, the US Food and Drug Administration (FDA) warned in a drug safety communication issued today.
 
To read more, please click here: https://www.rxlist.com/script/main/art.asp?articlekey=226865
 
Source: www.pharmacyexam.com